VNTH News Alert Vantage Health (VNTH) 0.1499 10/15/2014 12:0

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Vantage Health (VNTH) 0.1499 $VNTH

Vantage Health names Edward Rollins to board
M2 - Tue Sep 30, 4:50AM CDT
Vantage Health Inc (OTC: VNTH), a mobile health technology company, announced on Monday that it has appointed Edward Rollins to its board of directors.

Vantage Health Announces Appointment of Edward Rollins, Former Advisor to Four U.S. Presidents, to Its Board of Directors
Business Wire - Mon Sep 29, 7:30AM CDT
Vantage Health Inc., (OTCQB: VNTH) ("Vantage Health" or the "Company" today announced the appointment of Edward Rollins to its Board of Directors.

Vantage Health names Joseph C. Peters to board
M2 - Thu Sep 25, 4:37AM CDT
Vantage Health Inc (OTC:VNTH), a mobile health technology company, announced on Wednesday that it has appointed Joseph C. Peters to its board of directors, effective immediately.

Vantage Health Announces Appointment of Joseph C. Peters, Former White House Drug Policy Office's Acting Deputy Director for State and Local Affairs under Presidents Clinton and Bush, to Its Board of Directors
Business Wire - Wed Sep 24, 7:30AM CDT
Vantage Health Inc. (OTCQB:VNTH) ("Vantage Health" or the "Company" today announced the appointment of Joseph C. Peters to its Board of Directors, effective immediately. Mr. Peters will also serve as President of the company. Among other things, he will be involved in exploring possible applications of the Company's technology to narcotics detection. Mr. Peters will replace departing board member Will Rees.

Vantage Health appoints Dr Steven R. Steinhubl as board chairman
M2 - Wed Sep 24, 6:07AM CDT
Vantage Health Inc (OTC: VNTH), a mobile health technology company, on Tuesday announced that it has appointed Steven R. Steinhubl, MD, as chairman of the board. Dr Steinhubl replaces interim chairman Dr Kevin Buckman, who will remain with the company in an advisory capacity.

Vantage Health Names Dr. Steven R. Steinhubl, Director of Digital Medicine at Scripps Translational Science Institute, New Chairman of the Board
Business Wire - Tue Sep 23, 9:21AM CDT
Vantage Health Inc., (OTCQB:VNTH) ("Vantage Health" or (the "Company" today announced the appointment of Steven R. Steinhubl, M.D. as chairman of the board. Dr. Steinhubl replaces interim chairman, Dr. Kevin Buckman who will remain with the company in an advisory capacity.

Tony van Bijleveld, General Manager for Patheon/DPX, and Former General Manager Europe for Alliance Boots Walgreens, Appointed to the Vantage Health Board of Directors
Business Wire - Mon Sep 22, 11:20AM CDT
Vantage Health Inc. (OTCQB:VNTH) ("Vantage Health" or the "Company" today announced the appointment of Tony van Bijleveld as an independent member of the Board of Directors of Vantage Health, Inc.

Dr Kevin Buckman Named Chairman and CEO of Vantage Health
Business Wire - Tue Jul 29, 2:51PM CDT
Vantage Health (the "Company" (OTCQB:VNTH) today announced the appointment of Kevin Buckman MD FAAIM, DAAUCM, MACOEM, MRO as Chairman and CEO of the Company.

WEALTHMAKERS.COM Issues Report on Vantage Health
M2 - Wed Feb 26, 7:23AM CST
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued a new research report today on Vantage Health, Inc. (OTC: VNTH). The report highlights the short term bullish pattern that has emerged, the SqueezeTrigger Price of $0.095 and the projected short squeeze price target of $2.85 per share.

BUYINS.NET Issues Vantage Health SqueezeTrigger Report
M2 - Thu Feb 13, 7:27AM CST
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on Vantage Health (OTCBB: VNTH) after releasing the latest short sale data through February 11, 2014. The total aggregate number of shares shorted since March 2011 is approximately 23.35 million shares. Approximately 21.83% of daily trading volume is short selling. The SqueezeTrigger price for all VNTH shares shorted is $0.094. A short squeeze has just begun as shares of VNTH closed above the $0.094 SqueezeTrigger price.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 96

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading
Healthcare's Prevention Puzzle Needs Better Incentives

Updated Category News Views 113

When Savings Belong to the Next Plan A patient changing insurance plans can turn prevention into nobody’s asset. That is the uncomfortable little engine inside Russell Greenfield’s recent argument: an insurer may pay today for a program that helps prevent chronic illness, only to watch the eventual savings land with another plan after the member moves on. The person...

Continue Reading
Webster First Takes Aim at the Youth Money Literacy Gap

Updated Category News Views 86

Money mistakes get expensive long before anyone calls them mistakes. That is the uncomfortable point beneath Webster First Federal Credit Union CEO John Thomasian's November 20, 2026 discussion of financial literacy: plenty of young adults are entering the real financial world with a card, a loan offer, and a phone full of banking apps, but no sturdy framework for using...

Continue Reading
CVRx Lawsuit Puts Barostim Sales Claims Under Hard Scrutiny

Updated Category News Views 121

August 7 turned a compliance disclosure into a wrecking ball for CVRx shareholders. After the company revealed a Department of Justice civil investigative demand and cut its outlook, the stock dropped $3.55, or 60%, to close at $2.39. That is not a routine bad quarter getting punished. It is the market abruptly questioning whether the sales engine, the revenue it...

Continue Reading
Jalisco’s Culinary Push Puts Tourism Strategy in Focus

Updated Category News Views 50

A destination sells itself twice: first with a memorable meal, then with a reason to come back. Jalisco’s stated effort to connect the world’s cuisines through The 50 Best Gastronomic Experiences belongs in that second category. It is not merely restaurant chatter. It reads as part of a broader attempt to make the state’s tourism offering feel deeper, more varied...

Continue Reading
Nevada’s Space Academy Bid Has Assets, Not a Win Yet

Updated Category News Views 29

Desert acreage and a moon-landing backstory make for a handsome pitch, but Nevada is still standing at the starting line. The state has submitted its official response to NASA’s Request for Information for a proposed United States Space Academy, and the new promotional video is meant to show why the Silver State belongs in the conversation. Fair enough. There is real...

Continue Reading
Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 82

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
Rock Gate Buys Aviation Niche Player Blast Deflectors

Updated Category News Views 167

Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...

Continue Reading
Saturn and Tileward Put GPU Memory Back to Work Now

Updated Category News Views 49

GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...

Continue Reading
Greenberg Traurig Adds Privacy Muscle in Denver Office

Updated Category News Views 162

Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...

Continue Reading

Top 5 Most Recently Viewed Articles

Beta Glucan Market Set to Exceed USD 31 Billion by 2030

Updated Category News Views 56

Exploring the Growth of the Beta Glucan Market The beta glucan market is experiencing remarkable growth, largely driven by increasing awareness of its health benefits. More and more consumers are recognizing the importance of supporting their immune systems and managing cholesterol levels, which has led to a surge in demand across numerous sectors, including...

Continue Reading
AiPPT.com: Crafting the Next Era of AI-Driven Presentations

Updated Category News Views 177

Transforming Presentations with AiPPT.com In the evolving landscape of digital work, AiPPT.com stands out as a leading provider of AI-native tools that are reshaping the way presentations are crafted. As an advanced AI presentation maker, AiPPT.com is committed to enhancing user experiences by making the process of creating engaging and professional presentations much...

Continue Reading
Acme Mills Launches Natura: Revolutionizing Sustainable Fabrics

Updated Category News Views 244

Revolutionizing Textile Innovation with Natura Acme Mills Company, a recognized pioneer in textile manufacturing, has proudly unveiled its latest innovation, Natura. This new line of bio-based polylactic acid (PLA) fabrics aims to replace traditional petroleum-based materials such as PET, PP, and Nylon. With Natura, Acme Mills is not just promoting a product; it is...

Continue Reading
Class Action Alert for C3.ai, Inc. Investors - Join Now!

Updated Category News Views 123

Opportunity for C3.ai, Inc. Shareholders to Join Class Action Attention, shareholders of C3.ai, Inc. (NYSE: AI). A significant class action suit is currently underway, and your involvement could be crucial. If you purchased shares during the class period, there may be an opportunity for you to participate in a recovery process without the requirement of being a lead...

Continue Reading
EyePoint Pharmaceuticals: Innovations and Financial Insights

Updated Category News Views 224

EyePoint Pharmaceuticals Set to Showcase Q2 Financials EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pioneering company dedicated to developing advanced therapeutics for serious retinal diseases, plans to share its second quarter 2025 financial results. This announcement will be accompanied by a live conference call and webcast on a scheduled day, promising to provide...

Continue Reading